Bruker (BRKR) Other Non-Current Assets (2010 - 2026)
Bruker's (BRKR) quarterly Other Non-Current Assets came in at $832.2 million in Q1 2026, up 19.23% YoY from $698.0 million in Q1 2025, and down 0.55% on a QoQ basis from $836.8 million in Q4 2025.
Bruker (BRKR) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Bruker (BRKR) has 17 years of Other Non-Current Assets data on file, last reported at $832.2 million in Q1 2026.
- Quarterly Other Non-Current Assets rose 19.23% year-over-year to $832.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $832.2 million (up 19.23% YoY) and the FY2025 annual result came in at $836.8 million, up 259.6% from the prior year.
- Other Non-Current Assets declined to $832.2 million in Q1 2026, from $836.8 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $868.8 million in Q3 2025 to a low of $155.1 million in Q4 2022.
- A 5-year average of $415.4 million and a median of $284.3 million in 2022 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets sank 41.96% — and 2025, when it jumped 331.16%.
- Tracing BRKR's Other Non-Current Assets over 5 years: stood at $155.1 million in 2022, then increased by 18.63% to $184.0 million in 2023, then gained by 26.47% to $232.7 million in 2024, then jumped by 259.6% to $836.8 million in 2025, then decreased by 0.55% to $832.2 million in 2026.
- The last three Other Non-Current Assets figures came in at $832.2 million (Q1 2026), $836.8 million (Q4 2025), and $868.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Bruker | 9.16 Bn | 9.16 Bn | 416.00 Mn | 816.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 816.20 Mn |
| Mar 31, 2026 | 832.20 Mn |
| Dec 31, 2025 | 836.80 Mn |
| Sep 30, 2025 | 868.80 Mn |
| Jun 30, 2025 | 799.80 Mn |
| Mar 31, 2025 | 698.00 Mn |
| Dec 31, 2024 | 232.70 Mn |
| Sep 30, 2024 | 238.10 Mn |
| Jun 30, 2024 | 185.50 Mn |
| Mar 31, 2024 | 193.60 Mn |
| Dec 31, 2023 | 184.00 Mn |
| Sep 30, 2023 | 410.20 Mn |
| Jun 30, 2023 | 292.70 Mn |
| Mar 31, 2023 | 294.20 Mn |
| Dec 31, 2022 | 155.10 Mn |
| Sep 30, 2022 | 283.30 Mn |
| Jun 30, 2022 | 272.60 Mn |
| Mar 31, 2022 | 284.30 Mn |
| Dec 31, 2021 | 70.80 Mn |
| Sep 30, 2021 | 206.70 Mn |